News
Brandy Was a Hit Drink. Now It's a Poster Child for the Trade Wars. The preferred quaff of aristocrats and rappers is a key export for European luxury-drink makers, which are fighting tariff assaults ...
Brandy Was a Hit Drink. Now It's a Poster Child for the Trade Wars. The preferred quaff of aristocrats and rappers is a key export for European luxury-drink makers, which are fighting tariff assaults ...
4h
Zacks Investment Research on MSNWill Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...
Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR ...
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
According to UBS, the company’s next major driver is the SURPASS cardiovascular outcomes trial. The bank added that Eli Lilly ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
The actor is raising awareness of clinical trials for cancer in partnership with “GMA” sponsor Eli Lilly & Co.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results